ORSINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.669
EU - Europa 571
AS - Asia 223
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2.466
Nazione #
US - Stati Uniti d'America 1.668
DE - Germania 201
CN - Cina 156
SE - Svezia 113
IT - Italia 80
GB - Regno Unito 52
RU - Federazione Russa 41
SG - Singapore 36
FR - Francia 34
FI - Finlandia 18
VN - Vietnam 14
BE - Belgio 13
IN - India 9
CZ - Repubblica Ceca 6
IE - Irlanda 6
IR - Iran 3
HK - Hong Kong 2
KR - Corea 2
PL - Polonia 2
UA - Ucraina 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
HR - Croazia 1
JP - Giappone 1
MX - Messico 1
NA - Namibia 1
RO - Romania 1
Totale 2.466
Città #
Fairfield 270
Chandler 207
Woodbridge 145
Ashburn 135
Houston 116
Seattle 103
Cambridge 97
Nyköping 96
Wilmington 74
Ann Arbor 70
New York 61
Beijing 49
Bari 34
Singapore 29
Lawrence 26
Roxbury 25
Nanjing 22
Brooklyn 21
Marseille 18
Des Moines 17
Redwood City 15
Dong Ket 14
Brussels 13
San Diego 13
Jacksonville 11
Los Angeles 10
Nanchang 9
Paris 9
Guangzhou 8
Munich 8
Princeton 8
Hebei 7
Boardman 6
Dublin 6
London 6
Helsinki 5
Tianjin 5
Brno 4
Changsha 4
Falls Church 4
Inglewood 4
Jiaxing 4
Santa Clara 4
Jinan 3
Pune 3
Shenyang 3
Wuhan 3
Brindisi 2
Dearborn 2
Hong Kong 2
Indiana 2
Kilburn 2
Milan 2
New Delhi 2
Olomouc 2
Padova 2
Pulsano 2
San Mateo 2
Shanghai 2
Terni 2
Tiantai Chengguanzhen 2
Zhengzhou 2
Avigliano 1
Birmingham 1
Bisceglie 1
Böblingen 1
Chengdu 1
Clifton 1
Corato 1
Daejeon 1
Duncan 1
Frankfurt am Main 1
Fuzhou 1
Hefei 1
Heze 1
Kraków 1
Leawood 1
Mashhad 1
Melbourne 1
Miami 1
Monterrey 1
Naples 1
Ningbo 1
Norwalk 1
Omsk 1
Perugia 1
Piano Di Sorrento 1
Quzhou 1
San Francisco 1
Secunderabad 1
Seoul 1
Tappahannock 1
Tokyo 1
Torino 1
Torregrotta 1
Warsaw 1
Washington 1
Weifang 1
Xian 1
Yiwu 1
Totale 1.872
Nome #
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 157
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 137
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 134
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 123
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 122
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 120
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 116
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 112
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 102
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 102
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 100
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 98
null 94
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 90
null 87
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 86
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 74
null 73
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 71
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 69
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 67
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 59
null 58
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities 38
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 34
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 33
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 32
null 29
Genetic Pattern, Orthodontic and Surgical Management of Multiple Supplementary Impacted Teeth in a Rare, Cleidocranial Dysplasia Patient: A Case Report 28
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 27
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 24
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia 23
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter Of Diseases Or Prognostic Factors 20
Horizontal Gaze Palsy with Progressive Scoliosis with Overlapping Epilepsy and Learning Difficulties: A Case Report 11
A Rare Case of Concurrent 2q34q36 Duplication and 2q37 Deletion in a Neonate with Syndromic Features 8
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 5
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis 4
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition? 3
Totale 2.570
Categoria #
all - tutte 10.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020498 0 0 32 56 54 44 43 58 70 64 38 39
2020/2021396 14 70 18 39 38 28 15 68 12 36 27 31
2021/2022249 25 19 6 7 7 31 9 8 17 26 35 59
2022/2023473 44 81 28 34 55 57 4 58 84 5 9 14
2023/2024231 12 31 8 14 22 87 2 9 1 7 6 32
2024/202597 53 13 31 0 0 0 0 0 0 0 0 0
Totale 2.570